Crystal J Trujillo

Center for Simulation and Experimental Surgery, Faculty of Medicine, Pontificia Universidad Catolica de Chile, UC-Christus Health Network, Santiago, Chile.

6 publications 2003 – 2025

Research Overview

Crystal J Trujillo's research spans surgical education, global health equity, and immunology. Her work uses AI to improve feedback quality in procedural training, examines inequities in childhood vaccination coverage, and investigates the cellular mechanisms of immune tolerance in autoimmune disease.

Publications

Quality matters: Artificial intelligence-based assessment of feedback quality predicts technical skill improvement.

2025

Surgery

Kewalramani D, Roman DS, Lagos SA, Rammsy F, Villagran I +7 more

Plain English
Researchers tested whether an AI tool called Teach1 could assess the quality of feedback given to medical students learning a bedside procedure, and whether better feedback led to better skill gains. Better-quality feedback correlated directly with improved performance scores, with every 10% improvement in feedback quality translating to about one additional point of skill improvement. The findings show that AI-graded feedback quality is a meaningful driver of learning, offering a scalable way to raise the standard of teaching across surgical training programs.

View on PubMed

[Pelvic Exenteration in Rectal Cancer: A Paradigm That Must Change].

2025

Revista medica de Chile

Urrejola Schmied G, Larach Kattan JT, Trujillo CJ, Nervi Nattero B

View on PubMed

The Impact of COVID-19 Pandemic on Inequity in Routine Childhood Vaccination Coverage: A Systematic Review.

2022

Vaccines

Spencer N, Markham W, Johnson S, Arpin E, Nathawad R +4 more

Plain English
This systematic review examined whether COVID-19 lockdowns widened existing inequities in routine childhood vaccination rates, analyzing studies from January 2020 through early 2022. Evidence from 13 studies found moderate-to-strong signals that vaccination coverage dropped more steeply for disadvantaged groups — particularly infants and children in middle-income countries — compared to pre-pandemic baselines. The findings highlight that public health crises can deepen vaccination gaps, with lasting consequences for the most vulnerable children.

View on PubMed

Common causes for unsatisfactory Pap tests in a high-risk population: insights into a yet unresolved problem in gynecologic cytology.

2014

Journal of the American Society of Cytopathology

Quiroga-Garza G, Satrum LS, Trujillo CJ, Mody DR, Ge Y

Plain English
This study analyzed 276 unsatisfactory Pap tests (out of 56,563) from a high-risk population to identify the most common reasons for inadequate results and determine follow-up risks. Low squamous cell count was the leading cause, most often in women over 50 with a history of gynecologic cancer, and nearly 30% of patients who had follow-up testing showed abnormal results. The high rate of subsequent abnormalities underscores the importance of diligent follow-up when a Pap test cannot be evaluated.

View on PubMed

Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells.

2006

International immunology

Mohamood AS, Trujillo CJ, Zheng D, Jie C, Murillo FM +2 more

Plain English
Researchers studied how a mutation that disables Fas ligand — a key protein for deleting unwanted immune cells — affects regulatory T cells (Tregs), which suppress autoimmunity. Despite the mutation causing a buildup of T cells, Tregs expanded disproportionately and retained their suppressive function, likely because they are normally hypersensitive to Fas-mediated death. This compensatory expansion of Tregs helps explain why Fas pathway defects paradoxically protect against certain autoimmune diseases rather than causing them.

View on PubMed

B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production.

2003

Journal of immunology (Baltimore, Md. : 1950)

Hamad AR, Mohamood AS, Trujillo CJ, Huang CT, Yuan E +1 more

Plain English
This study showed that a population of unusual double-negative T cells that accumulate when the Fas immune deletion pathway is broken can suppress other T cells from proliferating and producing key immune-activating molecules. The suppression worked regardless of whether Fas signaling was present, required direct cell contact, and depended on the suppressor cells themselves being activated. These findings suggest that double-negative T cells serve as a backup system to prevent autoimmunity when the primary Fas-based deletion mechanism fails.

View on PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.